Cardiovascular Disease Awareness in Rheumatoid Arthritis and Knee Osteoarthritis
Launched by SISLI HAMIDIYE ETFAL TRAINING AND RESEARCH HOSPITAL · Jun 29, 2025
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Patients who apply to our Physical Medicine and Rehabilitation clinic and are followed up with the diagnosis of RA and (KOA) will be screened. Demographic values such as age, gender, height, weight, smoking and alcohol use, diseases and medications used, cardiovascular disease awareness will be assessed with the Cardiovascular Disease Risk Factors Knowledge Level (CARRF-KL), exercise levels with the International Physical Activity Questionnaire (IPAQ), and nutritional habits with the Nutrition Attitude Scale (NAS). Cardiovascular risk calculation will be made with the Framingham Risk Score....
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 40 and over
- • Patients diagnosed with rheumatoid arthritis or osteoarthritis
- • Volunteering to participate in the study
- Exclusion Criteria:
- • Patients who cannot ambulate
- • Patients who cannot be evaluated due to cognitive reasons
- • Those who are not receiving enteral nutrition or whose general condition is so poor that they cannot exercise
About Sisli Hamidiye Etfal Training And Research Hospital
Sisli Hamidiye Etfal Training and Research Hospital is a prominent healthcare institution dedicated to advancing medical research and education. Located in Istanbul, Turkey, the hospital is affiliated with the Ministry of Health and serves as a leading center for clinical trials, providing comprehensive services in various medical specialties. With a strong commitment to improving patient outcomes and contributing to scientific knowledge, Sisli Hamidiye Etfal fosters collaboration among healthcare professionals, researchers, and academic institutions. The hospital is equipped with state-of-the-art facilities and adheres to the highest ethical standards, ensuring the integrity and safety of its clinical research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
Banu Kuran, Professor, Medical Doctor
Study Director
Şişli Hamidiye Etfal Training and Research Hospital, İstanbul, Turkey
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported